Human APIs
Products
Our Products
Mirogabalin Besilate API
CAS No.: 1138245-13-2
Nilotinib Hydrochloride API
CAS No.: 923288-90-8
Niraparib Tosylate Monohydrate API
CAS No.: 923288-90-8
OMadacycline tosylate API
CAS No.: 923288-90-8
Parecoxib Sodium API
CAS No.: 198470-85-8
Ponatinib HCL API
CAS No.: 943319-70-8
Relugolix API
CAS No.: 737789-87-6
Rotigotine API
CAS No.: 99755-59-6
Ruxolitinib Phosphate API
CAS No.: 1092939-17-7
Silodosin API
CAS No.: 160970-54-7
SN-38 API
CAS No.: 138071-82-6
Sugammadex Sodium API
CAS No.: 343306-79-6
Qingmu Pharmaceutical is dedicated to the production of Bulk Drug API (Active Pharmaceutical Ingredients). Our manufacturing facility holds the coveted approvals of both the US FDA and the Chinese NMPA (GMP-PLANT), equipped with cutting-edge technology for the development and refinement of production processes. Our Human APIs are known for their exceptional cost-effectiveness, and we proudly manufacture over 30 different Pharma APIs.
With more than a decade of expertise, Qingmu Pharmaceutical stands at the forefront of Human APIs manufacturing in China. We firmly believe that ensuring access to quality healthcare is not a privilege but an integral part of life. We take pride in delivering globally acclaimed Human Health APIs at competitive prices, ensuring the supply of Pharma APIs on a worldwide scale.
Remarks: According to laws and regulations of People’s Republic of China, relevant information of Schedule II Controlled Substance APIs is not released here.
Disclaimer: The product that is still under patent protection can only be used in research and development, not for commercial purpose.
